PW
Patrick D Walsh
Director

Patrick D Walsh insider trades: Ani Pharmaceuticals (ANIP) stock buys and sales

Director, Ani Pharmaceuticals Last trade May 13, 2026 25 Form 4 filings
$2.3M
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2020
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Patrick reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 13, 2026ANIP↓ Sell$1.1M
Mar 3, 2026ANIP↓ Sell$445K
Nov 13, 2025ANIP↓ Sell$751K
Aug 15, 2025ANIP↓ Sell$801K
Mar 21, 2022ANIP↑ Buy$139K
Apr 20, 2021LNDC↑ Buy$113K
Mar 15, 2021ANIP↑ Buy$132K
Nov 9, 2020ANIP↑ Buy$130K
Aug 10, 2020ANIP↑ Buy$308K
Mar 23, 2020CDMO↑ Buy$97K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ANIP insiders

Open-market trades in the last 12 months

About Patrick D Walsh's insider trades

Patrick D Walsh is a director at Ani Pharmaceuticals (ANIP). Since Mar 23, 2020, Patrick has reported 6 open-market purchases worth $917K and 4 sales worth $3.1M on SEC Form 4. In the last 12 months: 3 sales ($2.3M).

Their filings also include grants and awards (15 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.